0001209191-15-009968.txt : 20150205 0001209191-15-009968.hdr.sgml : 20150205 20150205184437 ACCESSION NUMBER: 0001209191-15-009968 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150203 FILED AS OF DATE: 20150205 DATE AS OF CHANGE: 20150205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foundation Medicine, Inc. CENTRAL INDEX KEY: 0001488613 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271316416 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-418-2200 MAIL ADDRESS: STREET 1: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly David CENTRAL INDEX KEY: 0001320267 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36086 FILM NUMBER: 15581546 MAIL ADDRESS: STREET 1: 33171 PASEO CERVEZA CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-02-03 0 0001488613 Foundation Medicine, Inc. FMI 0001320267 Daly David C/O FOUNDATION MEDICINE, INC. 150 SECOND STREET CAMBRIDGE MA 02141 0 1 0 0 Chief Commercial Officer Stock Option (right to buy) 47.88 2015-02-03 4 A 0 75000 0.00 A 2025-02-03 Common Stock 75000 75000 D If certain performance milestones have been achieved this stock option vests (i) on the last trading day of the calendar quarter following the date of a determination by the Issuer's Compensation Committee that the performance milestones have been achieved, in an amount equal to 6.25% of the total number of shares underlying the option multiplied by the number of full and partial calendar quarters that have elapsed since the grant date, and (ii) 6.25% on the last trading day of each successive calendar quarter until 100% of the options are vested and exercisable. /s/ Robert Hesslein, as Attorney-in-Fact 2015-02-05